Sigachi Industries Limited (NSEI: SIGACHI)
Health Care · Pharmaceuticals · IN
Rs30.05
+10.15% today · -5.5% 1Y
Sigachi Industries Limited (NSEI: SIGACHI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $120.01M and employs 991 people.
Over the last twelve months the share price has lost 5.5%, trading between 16.65 and 46.73.
Tweenvest scores Sigachi Industries Limited across four factors: quality 59/100, value 36/100, growth 60/100, dividend 40/100. Its strongest factor is growth.
SIGACHI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $120.01M
- Revenue (TTM)
- $50.36M
- P/E
- 45.10
- EPS
- 0.67
- Dividend yield
- 0.33%
- Beta (5Y)
- 0.41
- 52-week high
- Rs46.73
- 52-week low
- Rs16.65
- Avg volume (3M)
- —
- Shares outstanding
- 382.12M
- Employees
- 991
- Next earnings
- —
About Sigachi Industries Limited
Sigachi Industries Limited, based in Hyderabad, India, specializes in the production and global distribution of microcrystalline cellulose and cellulose powder. Founded in 1989, the company supplies these essential materials to a diverse clientele across various sectors, including the pharmaceutical, nutraceutical, food and nutrition, cosmetic, and chemical industries, both within India and through exports.
- ISIN
- INE0D0K01022
- Founded
- 1989
- Listed since
- Nov 15, 2021
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,249.71 | -0.45% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.79 | +0.94% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.65 | -1.25% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.16% |
Figures last refreshed Aug 18, 2026.